Published in Eur J Cardiothorac Surg on December 01, 2004
The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol (2007) 2.18
Basal and oxidative stress-induced expression of metallothionein is decreased in ascending aortic aneurysms of bicuspid aortic valve patients. Circulation (2009) 1.67
Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol (2009) 1.65
Cardiac neural crest orchestrates remodeling and functional maturation of mouse semilunar valves. J Clin Invest (2010) 1.51
Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res (2008) 1.42
The effects of mitral regurgitation alone are sufficient for leaflet remodeling. Circulation (2008) 1.15
Thoracic aortic aneurysm: reading the enemy's playbook. Yale J Biol Med (2008) 1.04
Post-stenotic aortic dilatation. J Cardiothorac Surg (2006) 1.01
Biomechanical characterization of ascending aortic aneurysm with concomitant bicuspid aortic valve and bovine aortic arch. Acta Biomater (2013) 0.89
Dilatation of the ascending aorta in patients with congenitally bicuspid aortic valves. HSR Proc Intensive Care Cardiovasc Anesth (2012) 0.83
Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve. Heart Vessels (2011) 0.83
Bicuspid aortic valve disease and ascending aortic aneurysms: gaps in knowledge. Cardiol Res Pract (2012) 0.79
Insight into pathologic abnormalities in congenital semilunar valve disease based on advances in understanding normal valve microstructure and extracellular matrix. Cardiovasc Pathol (2011) 0.79
Elevation of matrix metalloproteinases in different areas of ascending aortic aneurysms in patients with bicuspid and tricuspid aortic valves. ScientificWorldJournal (2012) 0.79
Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease. Aorta (Stamford) (2013) 0.78
Extracellular matrix remodeling and cell phenotypic changes in dysplastic and hemodynamically altered semilunar human cardiac valves. Cardiovasc Pathol (2010) 0.77
Evaluation of Cardiovascular Changes in Children with BAVs. Pediatr Cardiol (2015) 0.77
Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic Effects. Int J Angiol (2015) 0.75
The surgical implications of bicuspid aortopathy. Ann Cardiothorac Surg (2013) 0.75
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg (2008) 3.04
Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg (2002) 3.03
Familial thoracic aortic aneurysms and dissections--incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg (2006) 2.61
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59
E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst (2009) 2.45
Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg (2006) 2.25
Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg (2007) 2.23
Straight deep hypothermic arrest: experience in 394 patients supports its effectiveness as a sole means of brain preservation. Ann Thorac Surg (2007) 2.15
Deaths associated with liposuction: case reports and review of the literature. J Forensic Sci (2002) 2.12
The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06
Is losartan the true panacea for aneurysm disease? PRO. Cardiol Clin (2010) 2.01
Deep hypothermic circulatory arrest effectively preserves neurocognitive function. Ann Thorac Surg (2013) 2.00
'Bovine' aortic arch - a marker for thoracic aortic disease. Cardiology (2012) 1.97
Current assessment and management of spontaneous pneumomediastinum: experience in 24 adult patients. Eur J Cardiothorac Surg (2004) 1.96
Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms. Circulation (2005) 1.79
Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta. J Thorac Cardiovasc Surg (2005) 1.76
Age does not limit quality of life improvement in cardiac valve surgery. J Am Coll Cardiol (2003) 1.55
Femoral cannulation is safe for type A dissection repair. Ann Thorac Surg (2004) 1.49
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg (2004) 1.48
Stenting the descending aorta during repair of type A dissection: technology looking for an application? J Thorac Cardiovasc Surg (2006) 1.45
Giant Basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res (2009) 1.43
Carotid intima-media thickness provides evidence that ascending aortic aneurysm protects against systemic atherosclerosis. Cardiology (2012) 1.42
Aortic Size Distribution in the General Population: Explaining the Size Paradox in Aortic Dissection. Cardiology (2015) 1.41
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg (2004) 1.40
Protecting the brain during aortic surgery: an enduring debate with unanswered questions. J Cardiothorac Vasc Anesth (2009) 1.40
Robot for coronary artery bypass grafting: a 'million dollar coat hanger'? Cardiology (2009) 1.39
Phantom aortic valve pressure gradient: discrepancies between cardiac catheterization and Doppler echocardiography. Anesth Analg (2005) 1.39
Can the occurrence of gastrointestinal bleeding in nonpulsatile left ventricular assist device patients provide clues for the reversal of arteriosclerosis? Cardiol Clin (2011) 1.38
Rescue coronary artery bypass grafting (CABG) after aortic composite graft replacement. J Card Surg (2009) 1.30
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray. Cancer (2004) 1.23
Natural history of thoracic aortic aneurysms. J Vasc Surg (2012) 1.21
Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet (2011) 1.20
A meta-analysis of deep hypothermic circulatory arrest versus moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion. Ann Cardiothorac Surg (2013) 1.19
Role of exertion or emotion as inciting events for acute aortic dissection. Am J Cardiol (2007) 1.19
Transmural inflammation by interferon-gamma-producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms. FASEB J (2005) 1.17
Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. Arch Otolaryngol Head Neck Surg (2005) 1.16
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer (2012) 1.16
Gene expression signature in peripheral blood detects thoracic aortic aneurysm. PLoS One (2007) 1.15
Consensus on hypothermia in aortic arch surgery. Ann Cardiothorac Surg (2013) 1.13
Sun's procedure for complex aortic arch repair: total arch replacement using a tetrafurcate graft with stented elephant trunk implantation. Ann Cardiothorac Surg (2013) 1.13
Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res (2010) 1.13
Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist (2006) 1.11
Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev Cardiovasc Ther (2008) 1.11
Importance of false lumen thrombosis in type B aortic dissection prognosis. J Thorac Cardiovasc Surg (2012) 1.11
Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope (2010) 1.10
Medical therapy of thoracic aortic aneurysms: are we there yet? Circulation (2011) 1.09
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors. Clin Cancer Res (2009) 1.08
Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res (2005) 1.08
Utility of the aortic fenestration technique in the management of acute aortic dissections. Ann Thorac Cardiovasc Surg (2007) 1.08
The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg (2013) 1.08
Pro: standard CABG is the procedure of choice for myocardial revascularization. J Cardiothorac Vasc Anesth (2003) 1.07
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.06
Thoracic Surgery Directors Association Award. What is the optimal management of late-presenting survivors of acute type A aortic dissection? Ann Thorac Surg (2007) 1.04
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas. BMC Cancer (2006) 1.04
Deep hypothermic circulatory arrest in patients with high cognitive needs: full preservation of cognitive abilities. Ann Thorac Surg (2009) 1.03
Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin Cancer Res (2010) 1.02
Quadricuspid aortic valve with aortic insufficiency: case report and review of the literature. J Card Surg (2007) 1.02
Deep hypothermic circulatory arrest. Ann Cardiothorac Surg (2013) 1.01
Elastofibromatous polyp of the sigmoid colon--a case report and review of gastrointestinal elastofibromas. Can J Gastroenterol (2003) 1.01
Medical management of acute type A aortic dissection. Ann Thorac Cardiovasc Surg (2009) 1.00
Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta. J Thorac Cardiovasc Surg (2002) 1.00
Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis. Otolaryngol Head Neck Surg (2009) 0.99
Safety of thoracic aortic surgery in the present era. Ann Thorac Surg (2007) 0.98
Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas. Cancer J (2006) 0.98
Does straight deep hypothermic circulatory arrest suffice for brain preservation in aortic surgery? Semin Thorac Cardiovasc Surg (2010) 0.97
Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery (2013) 0.96
Dermoid cyst of the pancreas: a case report with literature review. J Radiol Case Rep (2012) 0.95
Concurrent intracranial and thoracic aortic aneurysms. Am J Cardiol (2009) 0.95
Atenolol versus Losartan in Marfan's Syndrome. N Engl J Med (2015) 0.93
Adenoid cystic carcinoma of the cervix. Gynecol Oncol (2005) 0.92
Sun's procedure for chronic type A aortic dissection: total arch replacement using a tetrafurcate graft with stented elephant trunk implantation. Ann Cardiothorac Surg (2013) 0.92
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab. J Cancer Res Clin Oncol (2014) 0.92
Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women. BMC Cancer (2010) 0.92
Full-term gestation and transvaginal delivery after wide resection of an abdominal desmoid tumor during pregnancy. J Surg Oncol (2005) 0.91
Thoracic aortic aneurysm: reading the enemy's playbook. Curr Probl Cardiol (2008) 0.91
Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma. Clin Cancer Res (2011) 0.90
Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway. Ann Hematol (2010) 0.90
Heart failure 2012. Cardiol Res Pract (2012) 0.89
Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB (Oxford) (2012) 0.88
Clinical factors predictive of malignant and premalignant cystic neoplasms of the pancreas: a single institution experience. HPB (Oxford) (2009) 0.87
Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg (2002) 0.87
Quality of life after aortic valve replacement with tissue and mechanical implants. J Thorac Cardiovasc Surg (2004) 0.87
Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease. Ann Surg Oncol (2010) 0.86
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Clin Cancer Res (2005) 0.86
In search of blood tests for thoracic aortic diseases. Ann Thorac Surg (2010) 0.85
Weight lifting and rupture of silent aortic aneurysms. JAMA (2003) 0.85
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA). Cancer Sci (2008) 0.85
Comparison of the effect on long-term outcomes in patients with thoracic aortic aneurysms of taking versus not taking a statin drug. Am J Cardiol (2012) 0.84
Dermatofibrosarcoma protuberans: a case series of 16 patients treated in a single institution with literature review. Anticancer Res (2010) 0.84
Images in cardiovascular medicine. Massive paradoxical embolism: caught in the act. Circulation (2004) 0.83
Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest (2003) 0.83
Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites. Arch Otolaryngol Head Neck Surg (2009) 0.83
Her-2 protein expression, cellular localization, and gene amplification in colorectal carcinoma. Appl Immunohistochem Mol Morphol (2007) 0.83
What operation for acute type A dissection? J Thorac Cardiovasc Surg (2002) 0.83